conference reports
Kidney cancer: every minute counts
Wednesday, 16 November 2011- The 3rd European Multidisciplinary Meeting on Urological Cancers (EMUC) raised a vast array of controversial issues in onco-urology and offered essential updates, providing common ground for building...
By Evgenia Starkova
11th CEM, first prize best abstract: oncocytic papillary renal cell carcinoma in clinical praxis
Monday, 7 November 2011- Researchers from the Czech Republic bagged the first prize from Richard Wolf for the best abstract presentation at the recently held EAU 11th Central European Meeting (CEM) held in Timisoara,...
Posted by: JV
EAU Annual Congress: first prize Best Abstract by a resident
Tuesday, 12 April 2011- J.H.M. Berkers (Belgium) and colleagues won the first prize for Best Abstract by a resident during the 26th Annual EAU Congress recently held in Vienna, Austria. Below is the winning abstract, unedited and...
Edited by: JV
New kidney cancer surgery technique could reduce organ damage
Thursday, 11 November 2010- A new method of surgery for kidney cancer could help reduce organ damage, leading to more successful treatment of the disease, according to researchers who presented their findings in Liverpool, the...
Edited by: JV
Hemostasis of the lodge after resected tumor: crucial factor after laparoscopic kidney tumourectomy
Tuesday, 14 September 2010- Piotr Petrasz of the Pomeranian Medical University, Urology, Szczecin, Poland won the first prize granted by Richard Wolf for the best abstract during the 4th North Eastern European Meeting held in...
Edited by: JV
Temsirolimus and bevacizumab combi in metastatic RCC: TORAVA trial
Wednesday, 2 June 2010- Temsirolimus (T) and bevacizumab (B) have been approved for the treatment of metastatic renal cell carcinoma (mRCC). The T-B combination has proven feasible at full doses of each agent with promising...
Edited by: JV
Robot-assisted laparoscopic partial nephrectomy: a feasible option for patients
Thursday, 29 April 2010- Laparoscopic partial nephrectomy (LPN) has established a place as a minimal invasive, nephron sparing treatment for T1 renal tumours. In a poster session at the recently concluded 25th Anniversary EAU...
Edited by: JV
Preliminary experience with sorafenib and cytoreductive nephrectomy in mRCC
Wednesday, 28 April 2010- The role of cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC) in the targeted therapy era is unknown and is being addressed in randomised trials.
A.Finelli and colleagues...
Edited by: JV
Surgery plays a major role even in patients with mRCC
Sunday, 18 April 2010- Surgery plays a major role in patients with metastatic renal cell carcinoma (mRCC) despite the development of new drugs known as 'targeted therapies,' said Prof. Ziya Kirkali during a course on surgery and...
Edited by Joel Vega
EAU Congress: plenary session tackles medical therapy for advanced cancer
Saturday, 17 April 2010- Advances in the management of kidney cancer were taken in a case discussion with experts saying that surgery still plays a major role in metastatic renal cell carcinoma (mRCC) despite the recent entry of...
By Joel Vega
